Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19... see more

TSXV:VXL - Post Discussion

Vaxil Bio Ltd > Oral was supposed to be a game changer
View:
Post by bligicka on Jan 28, 2021 7:33pm

Oral was supposed to be a game changer

I'm having a hard time wrapping my head around the expression "Very Preliminary experiment" 

Considering the speed at which Vaxil operates the Oral could take a year to develope and collect data ect....

We still don't have proper data on the immune response from Israel experiments ....just stuff like the mice are feeling ok .....lol


In addition, Vaxil has completed the exploratory oral experiment that was announced last month. In this very preliminary experiment, Vaxil was able to establish that it is possible to observe an immune response in some animals after oral delivery of the vaccine candidate. This supports proceeding with next steps to validate this response. It should be noted that this is a very preliminary result. Further updates will be provided when available.
Comment by George141 on Jan 28, 2021 7:40pm
There are issues with Phizer vaccine. Global News reports a male nurse in Ottawa was diagnosed after taking 2nd half of the vaccine. in addition there are shortages reported...when they would have had months to  plan this out...VXL is on the right path...
Comment by bligicka on Jan 28, 2021 7:58pm
Are you going to pass when its your turn for the Phizer Vaccine ??? I certainly not going to wait for Vaxil to get to market .......something stinks here  if their so sure they have a cure for covid ...why not start Phase 1 in parallel or at least start the process ....these guys wait and wait for more data where is their confidence to move forward to shave some time off the process 
Comment by George141 on Jan 28, 2021 10:30pm
..I think the right vaccine will depend on one's DNA. Diffrent strokes for different folks. I am happy to wait altough I could not Phizer out...Would I trust VXL...once they got approval..I would if it was approved and matched my DNA... 
Comment by George141 on Jan 28, 2021 10:33pm
meant to say "I would not count Phizer out" if it matched my profile..
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities